CTOs on the Move

Ohr Pharmaceutical

www.ohrpharmaceutical.com

 
Ohr Pharmaceutical, Inc. (OHRP) is an ophthalmology research and development company. The company`s lead product, Squalamine (OHR-102), is currently being studied as an eye drop formulation in several company sponsored and investigator sponsored Phase II clinical trials for various back-of-the-eye diseases, including the wet form of age-related macular degeneration, retinal vein occlusion, diabetic macular edema, and proliferative diabetic retinopathy. In addition, Ohr has a sustained release micro fabricated micro-particle ocular drug delivery platform with several preclinical drug product candidates in development for glaucoma, steroid-induced glaucoma, ocular allergies, and protein drug delivery.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details
Irach Taraporewala
 Chief Technology Officer Profile

Similar Companies

Northern New England Compounding Pharmacy

Northern New England Compounding Pharmacy is a Littleton, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Yusef Manufacturing Labs

Yusef Manufacturing Labs is a Kaysville, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

InnerScope Hearing Technologies

Homepage for InnerScope Hearing Technologies, a hearing care company who sells Direct-to-Consumer Hearing Aids.

Cardioxyl Pharmaceuticals

Cardioxyl Pharmaceuticals is a Chapel Hill, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Immune-Onc Therapeutics

Immune-Onc Therapeutics, Inc. is a privately held cancer immunotherapy company dedicated to the discovery and development of novel biologic treatments for cancer patients.